title: Putting the IMPACT study into perspective: should CMV prophylaxis be extended to 6 months for high risk transplants?
authors.forename: D R
authors.initials: DR
authors.lastname: Snydman
mesh_terms: D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000008:administration & dosage* / Q000627:therapeutic use; D016377:Organ Transplantation
chemical_list: D015774:Ganciclovir